628 related articles for article (PubMed ID: 27001593)
1. Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
Milowsky MI; Rumble RB; Booth CM; Gilligan T; Eapen LJ; Hauke RJ; Boumansour P; Lee CT
J Clin Oncol; 2016 Jun; 34(16):1945-52. PubMed ID: 27001593
[TBL] [Abstract][Full Text] [Related]
2. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
Witjes JA; Bruins HM; Cathomas R; Compérat EM; Cowan NC; Gakis G; Hernández V; Linares Espinós E; Lorch A; Neuzillet Y; Rouanne M; Thalmann GN; Veskimäe E; Ribal MJ; van der Heijden AG
Eur Urol; 2021 Jan; 79(1):82-104. PubMed ID: 32360052
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline.
Rudin CM; Ismaila N; Hann CL; Malhotra N; Movsas B; Norris K; Pietanza MC; Ramalingam SS; Turrisi AT; Giaccone G
J Clin Oncol; 2015 Dec; 33(34):4106-11. PubMed ID: 26351333
[TBL] [Abstract][Full Text] [Related]
4. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
[TBL] [Abstract][Full Text] [Related]
5. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.
Sulman EP; Ismaila N; Armstrong TS; Tsien C; Batchelor TT; Cloughesy T; Galanis E; Gilbert M; Gondi V; Lovely M; Mehta M; Mumber MP; Sloan A; Chang SM
J Clin Oncol; 2017 Jan; 35(3):361-369. PubMed ID: 27893327
[TBL] [Abstract][Full Text] [Related]
6. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.
Witjes JA; Compérat E; Cowan NC; De Santis M; Gakis G; Lebret T; Ribal MJ; Van der Heijden AG; Sherif A;
Eur Urol; 2014 Apr; 65(4):778-92. PubMed ID: 24373477
[TBL] [Abstract][Full Text] [Related]
7. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
Alfred Witjes J; Max Bruins H; Carrión A; Cathomas R; Compérat E; Efstathiou JA; Fietkau R; Gakis G; Lorch A; Martini A; Mertens LS; Meijer RP; Milowsky MI; Neuzillet Y; Panebianco V; Redlef J; Rink M; Rouanne M; Thalmann GN; Sæbjørnsen S; Veskimäe E; van der Heijden AG
Eur Urol; 2024 Jan; 85(1):17-31. PubMed ID: 37858453
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline.
Schneider BJ; Daly ME; Kennedy EB; Antonoff MB; Broderick S; Feldman J; Jolly S; Meyers B; Rocco G; Rusthoven C; Slotman BJ; Sterman DH; Stiles BM
J Clin Oncol; 2018 Mar; 36(7):710-719. PubMed ID: 29106810
[TBL] [Abstract][Full Text] [Related]
9. Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Quon H; Vapiwala N; Forastiere A; Kennedy EB; Adelstein DJ; Boykin H; Califano JA; Holsinger FC; Nussenbaum B; Rosenthal DI; Siu LL; Waldron JN
J Clin Oncol; 2017 Dec; 35(36):4078-4090. PubMed ID: 29064744
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant and adjuvant treatments in muscle-invasive bladder cancer: Where are we?
Osanto S; Álvarez Gómez de Segura C
Arch Esp Urol; 2020 Dec; 73(10):971-985. PubMed ID: 33269716
[TBL] [Abstract][Full Text] [Related]
11. SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018).
González Del Alba A; De Velasco G; Lainez N; Maroto P; Morales-Barrera R; Muñoz-Langa J; Pérez-Valderrama B; Basterretxea L; Caballero C; Vazquez S
Clin Transl Oncol; 2019 Jan; 21(1):64-74. PubMed ID: 30565086
[TBL] [Abstract][Full Text] [Related]
12. [Update of the Clinical Guidelines of the European Association of Urology on muscle-invasive and metastatic bladder carcinoma].
Stenzl A; Cowan NC; De Santis M; Jakse G; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
Actas Urol Esp; 2010 Jan; 34(1):51-62. PubMed ID: 20223133
[TBL] [Abstract][Full Text] [Related]
13. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
Macleod LC; Yabes JG; Yu M; Fam MM; Hale NE; Turner RM; Lopa SH; Gingrich JR; Borza T; Skolarus TA; Davies BJ; Jacobs BL
Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530
[TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.
Basch EM; Somerfield MR; Beer TM; Carducci MA; Higano CS; Hussain MH; Scher HI;
J Clin Oncol; 2007 Nov; 25(33):5313-8. PubMed ID: 17925542
[TBL] [Abstract][Full Text] [Related]
15. Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline.
Nekhlyudov L; Lacchetti C; Davis NB; Garvey TQ; Goldstein DP; Nunnink JC; Ninfea JIR; Salner AL; Salz T; Siu LL
J Clin Oncol; 2017 May; 35(14):1606-1621. PubMed ID: 28240970
[TBL] [Abstract][Full Text] [Related]
16. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA;
Eur Urol; 2011 Jun; 59(6):1009-18. PubMed ID: 21454009
[TBL] [Abstract][Full Text] [Related]
17. Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.
Chen RC; Rumble RB; Loblaw DA; Finelli A; Ehdaie B; Cooperberg MR; Morgan SC; Tyldesley S; Haluschak JJ; Tan W; Justman S; Jain S
J Clin Oncol; 2016 Jun; 34(18):2182-90. PubMed ID: 26884580
[TBL] [Abstract][Full Text] [Related]
18. Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy.
Nielsen N; Wrist Lam G; Fabrin K; Holt P; Thind PO; Jensen JB
Scand J Urol; 2019 Aug; 53(4):213-216. PubMed ID: 31174449
[No Abstract] [Full Text] [Related]
19. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer.
Griggs JJ; Somerfield MR; Anderson H; Henry NL; Hudis CA; Khatcheressian JL; Partridge AH; Prestrud AA; Davidson NE
J Clin Oncol; 2011 Oct; 29(29):3939-42. PubMed ID: 21900112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
